Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures

Dejan Juric, Sanja Sale, Robert A. Hromas, Ron Yu, Yan Wang, George E. Duran, Robert Tibshirani, Lawrence Einhorn, Branimir I. Sikic

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Germ cell tumors (GCTs) of the testis are the predominant cancer among young men. We analyzed gene expression profiles of 50 GCTs of various subtypes, and we compared them with 443 other common malignant tumors of epithelial, mesenchymal, and lymphoid origins. Significant differences in gene expression were found among major histological subtypes of GCTs, and between them and other malignancies. We identified 511 genes, belonging to several critical functional groups such as cell cycle progression, cell proliferation, and apoptosis, to be significantly differentially expressed in GCTs compared with other tumor types. Sixty-five genes were sufficient for the construction of a GCT class predictor of high predictive accuracy (100% training set, 96% test set), which might be useful in the diagnosis of tumors of unknown primary origin. Previously described diagnostic and prognostic markers were found to be expressed by the appropriate GCT subtype (AFP, POU5F1, POV1, CCND2, and KIT). Several additional differentially expressed genes were identified in teratomas (EGR1 and MMP7), yolk sac tumors (PTPNT3 and FN1), and seminomas (NR6A1, DPPA4, and JRX1). Dynamic computation of interaction networks and mapping to existing pathways knowledge databases revealed a potential role of EGR1 in p21-induced cell cycle arrest and intrinsic chemotherapy resistance of mature teratomas.

Original languageEnglish
Pages (from-to)17763-17768
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number49
DOIs
StatePublished - Dec 6 2005

Fingerprint

Germ Cell and Embryonal Neoplasms
Gene Expression Profiling
Neoplasms
Teratoma
Unknown Primary Neoplasms
Genes
Endodermal Sinus Tumor
Seminoma
Testicular Neoplasms
Cell Cycle Checkpoints
Transcriptome
Cell Cycle
Cell Proliferation
Databases
Apoptosis
Carcinoma
Gene Expression
Drug Therapy

Keywords

  • DNA microarrays
  • Molecular interaction networks
  • Testicular cancer
  • Unknown primary tumors

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. / Juric, Dejan; Sale, Sanja; Hromas, Robert A.; Yu, Ron; Wang, Yan; Duran, George E.; Tibshirani, Robert; Einhorn, Lawrence; Sikic, Branimir I.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 49, 06.12.2005, p. 17763-17768.

Research output: Contribution to journalArticle

Juric, Dejan ; Sale, Sanja ; Hromas, Robert A. ; Yu, Ron ; Wang, Yan ; Duran, George E. ; Tibshirani, Robert ; Einhorn, Lawrence ; Sikic, Branimir I. / Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 49. pp. 17763-17768.
@article{b16264970f544d1e9d707a79810c1c56,
title = "Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures",
abstract = "Germ cell tumors (GCTs) of the testis are the predominant cancer among young men. We analyzed gene expression profiles of 50 GCTs of various subtypes, and we compared them with 443 other common malignant tumors of epithelial, mesenchymal, and lymphoid origins. Significant differences in gene expression were found among major histological subtypes of GCTs, and between them and other malignancies. We identified 511 genes, belonging to several critical functional groups such as cell cycle progression, cell proliferation, and apoptosis, to be significantly differentially expressed in GCTs compared with other tumor types. Sixty-five genes were sufficient for the construction of a GCT class predictor of high predictive accuracy (100{\%} training set, 96{\%} test set), which might be useful in the diagnosis of tumors of unknown primary origin. Previously described diagnostic and prognostic markers were found to be expressed by the appropriate GCT subtype (AFP, POU5F1, POV1, CCND2, and KIT). Several additional differentially expressed genes were identified in teratomas (EGR1 and MMP7), yolk sac tumors (PTPNT3 and FN1), and seminomas (NR6A1, DPPA4, and JRX1). Dynamic computation of interaction networks and mapping to existing pathways knowledge databases revealed a potential role of EGR1 in p21-induced cell cycle arrest and intrinsic chemotherapy resistance of mature teratomas.",
keywords = "DNA microarrays, Molecular interaction networks, Testicular cancer, Unknown primary tumors",
author = "Dejan Juric and Sanja Sale and Hromas, {Robert A.} and Ron Yu and Yan Wang and Duran, {George E.} and Robert Tibshirani and Lawrence Einhorn and Sikic, {Branimir I.}",
year = "2005",
month = "12",
day = "6",
doi = "10.1073/pnas.0509082102",
language = "English",
volume = "102",
pages = "17763--17768",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "49",

}

TY - JOUR

T1 - Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures

AU - Juric, Dejan

AU - Sale, Sanja

AU - Hromas, Robert A.

AU - Yu, Ron

AU - Wang, Yan

AU - Duran, George E.

AU - Tibshirani, Robert

AU - Einhorn, Lawrence

AU - Sikic, Branimir I.

PY - 2005/12/6

Y1 - 2005/12/6

N2 - Germ cell tumors (GCTs) of the testis are the predominant cancer among young men. We analyzed gene expression profiles of 50 GCTs of various subtypes, and we compared them with 443 other common malignant tumors of epithelial, mesenchymal, and lymphoid origins. Significant differences in gene expression were found among major histological subtypes of GCTs, and between them and other malignancies. We identified 511 genes, belonging to several critical functional groups such as cell cycle progression, cell proliferation, and apoptosis, to be significantly differentially expressed in GCTs compared with other tumor types. Sixty-five genes were sufficient for the construction of a GCT class predictor of high predictive accuracy (100% training set, 96% test set), which might be useful in the diagnosis of tumors of unknown primary origin. Previously described diagnostic and prognostic markers were found to be expressed by the appropriate GCT subtype (AFP, POU5F1, POV1, CCND2, and KIT). Several additional differentially expressed genes were identified in teratomas (EGR1 and MMP7), yolk sac tumors (PTPNT3 and FN1), and seminomas (NR6A1, DPPA4, and JRX1). Dynamic computation of interaction networks and mapping to existing pathways knowledge databases revealed a potential role of EGR1 in p21-induced cell cycle arrest and intrinsic chemotherapy resistance of mature teratomas.

AB - Germ cell tumors (GCTs) of the testis are the predominant cancer among young men. We analyzed gene expression profiles of 50 GCTs of various subtypes, and we compared them with 443 other common malignant tumors of epithelial, mesenchymal, and lymphoid origins. Significant differences in gene expression were found among major histological subtypes of GCTs, and between them and other malignancies. We identified 511 genes, belonging to several critical functional groups such as cell cycle progression, cell proliferation, and apoptosis, to be significantly differentially expressed in GCTs compared with other tumor types. Sixty-five genes were sufficient for the construction of a GCT class predictor of high predictive accuracy (100% training set, 96% test set), which might be useful in the diagnosis of tumors of unknown primary origin. Previously described diagnostic and prognostic markers were found to be expressed by the appropriate GCT subtype (AFP, POU5F1, POV1, CCND2, and KIT). Several additional differentially expressed genes were identified in teratomas (EGR1 and MMP7), yolk sac tumors (PTPNT3 and FN1), and seminomas (NR6A1, DPPA4, and JRX1). Dynamic computation of interaction networks and mapping to existing pathways knowledge databases revealed a potential role of EGR1 in p21-induced cell cycle arrest and intrinsic chemotherapy resistance of mature teratomas.

KW - DNA microarrays

KW - Molecular interaction networks

KW - Testicular cancer

KW - Unknown primary tumors

UR - http://www.scopus.com/inward/record.url?scp=29144450911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144450911&partnerID=8YFLogxK

U2 - 10.1073/pnas.0509082102

DO - 10.1073/pnas.0509082102

M3 - Article

VL - 102

SP - 17763

EP - 17768

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 49

ER -